A Bcl-x(L) transgene promotes malignant conversion of chemically initiated skin papillomas

Cancer Research

Volumn 58, Issue 10, 1998, Pages 2111-2116

  Pena, John C ^a,b   Rudin, Charles M ^a,b   Thompson, Craig B ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL MUTAGEN; 7,12 DIMETHYLBENZ[A]ANTHRACENE; BCL2L1 PROTEIN, MOUSE; CARCINOGEN; PROTEIN BCL 2; PROTEIN BCL X;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GENETICS; CANCER INVASION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; MOUSE; PRIORITY JOURNAL; PROMOTER REGION; SKIN PAPILLOMA; TRANSGENE; ANIMAL; APOPTOSIS; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; DISEASE COURSE; DRUG EFFECT; GENETICS; PAPILLOMA; PATHOLOGY; SKIN TUMOR; TRANSGENIC MOUSE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; APOPTOSIS; BCL-X PROTEIN; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; MICE; MICE, TRANSGENIC; PAPILLOMA; PROTO-ONCOGENE PROTEINS C-BCL-2; SKIN NEOPLASMS; TRANSGENES;

EID: 0032523237     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
2. Kinzler, K. W., and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell, 87: 159-170, 1996.
3. Fearon, E. R., Hamilton, S. R., and Vogelstein, B. Clonal analysis of human colorectal tumors. Science (Washington DC), 238: 193-197, 1987.
4. Bishop, J. M. Molecular themes in oncogenesis. Cell, 64: 235-248, 1991.
5. Ruther, U., Muller, W., Sumida, T., Tokuhisa, T., Rajewsky, K., and Wagner, E. F. c-fos expression interferes with thymus development in transgenic mice. Cell, 53: 847-856, 1988.
6. Schuh, A. C., Keating, S. J., Monteclaro, F. S., Vogt, P. K., and Breitman, M. L. Obligatory wounding requirement for tumorigenesis in v-jun transgenic mice. Nature (Lond.), 346: 756-760, 1990.
7. Greenhalgh, D. A., Rothnagel, J. A., Quintanilla, M. I., Orengo, C. C., Gagne, T. A., Bundman, D. S., Longley, M. A., and Roop, D. R. Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v-Ha-ras oncogene. Mol. Carcinog., 7: 99-110, 1993.
8. Spalding, J. W., Momma, J., Elwell, M. R., and Tennant, R. W. Chemically induced skin carcinogenesis in a transgenic mouse line (TG · AC) carrying a v-Ha-ras gene. Carcinogenesis, 14: 1335-1341, 1993.
9. Strasser, A., Harris, A. W., Bath, M. L., and Cory, S. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature (Lond.), 348: 331-333, 1990.
10. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (Lond.), 356: 215-21, 1992.
11. Serrano, M., Lee, H., Chin, L., Cordon-Cardo, C., Beach, D., and DePinho, R. A. Role of the INK4a locus in tumor suppression and cell mortality. Cell, 85: 27-37, 1996.
12. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., and Hancock, D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69: 119-28, 1992.
13. Lowe, S. W., Jacks, T., Housman, D. E., and Ruley, H. E. Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc. Natl. Acad. Sci. USA, 91: 2026-2030, 1994.
14. Harvey, M., Sands, A. T., Weiss, R. S., Hegi, M. E., Wiseman, R. W., Pantazis, P., Giovanella, B. C., Tainsky, M. A., Bradley, A., and Donehower, L. A. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene, 8: 2457-2467, 1993.
15. Ko, L. J., and Prives, C. p53: puzzle and paradigm. Genes Dev., 10: 1054-1072, 1996.
16. Yuspa, S. H., and Poirier, M. C. Chemical carcinogenesis from animal models to molecular models in one decade. Adv. Cancer Res., 50: 25-70, 1988.
17. Greenhalgh, D. A., and Roop, D. R. Dissecting molecular carcinogenesis: development of transgenic mouse models by epidermal gene targeting. Adv. Cancer Res., 64: 247-296, 1994.
18. Strickland, P. T. Tumor induction in Sencar mice in response to ultraviolet radiation. Carcinogenesis, 3: 1487-1489, 1982.
19. DiGiovanni, J. Multistage carcinogenesis in mouse skin. Pharmacol. Ther., 54: 63-128, 1992.
20. Shubik, P., Baserge, R., and Titchie, A. C. The life and progression of induced skin tumors in mice. Br. J. Cancer, 7: 342-351, 1953.
21. Ames, B. N., and Gold, L. S. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science (Washington DC), 249: 970-971, 1990.
22. Fraga, C. G., Shigenaga, M. K., Park, J-W., Degan, P., and Ames, B. N. Oxidative damage to DNA during aging: 8-hydroxy-2′-deoxyguanosine in rat organ DNA and urine. Proc. Natl. Acad. Sci. USA, 87: 4533-4537, 1990.
23. Boutwell, R. K. The function and mechanisms of promoters of carcinogenesis. Crit. Rev. Toxicol., 2: 419-437, 1974.
24. Cerutti, P. A. Prooxidant states and tumor promotion. Science (Washington DC), 227: 375-381, 1985.
25. Burns, F. J., Vanderlann, M., and Sivak, A. Regression of chemically-induced papillomas in mouse skin. Proc. Am. Assoc. Cancer Res., 15: 89-93, 1974.
26. Burns, F. J., Vanderlaan, M., Sivak, A., and Albert, R. E. Regression kinetics of mouse skin papillomas. Cancer Res., 36: 1422-1427, 1976.
27. Hennings, H., Shores, R., Wenk, M. L., Spangler, E. F., Tarone, R., and Yuspa, S. H. Malignant conversion of mouse skin tumours is increased by tumour initiators and unaffected by tumour promoters. Nature (Lond.), 304: 67-69, 1983.
28. Vassar, R., Rosenberg, M., Ross, S., Tyner, A., and Fuchs, E. Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc. Natl. Acad. Sci. USA, 86: 1563-1567, 1989.
29. Pena, J. C., Fuchs, E., and Thompson, C. B. Bcl-x expression influences keratinocyte cell survival but not terminal differentiation. Cell Growth Differ., 8: 619-629, 1997.
30. Quintanilla, M., Brown, K., Ramsden, M., and Balmain, A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature (Lond.), 322: 78-80, 1986.
31. Leder, A., Kuo, A., Cardiff, R. D., Sinn, E., and Leder, P. v-Ha-Ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. Proc. Natl. Acad. Sci. USA, 87: 9178-9182, 1990.
32. Hennings, H., Shores, R., Mitchell, P., Spangler, E. F., and Yuspa, S. H. Induction of papillomas with a high probability of conversion to malignancy. Carcinogenesis, 6: 1607-1610, 1985.
33. Yang, E., and Korsmeyer, S. J. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood. 88: 386-401, 1996.
34. Danno, K., and Horio, T. Sunburn cell: factors involved in its formation. Photochem. Photobiol., 45: 683-690, 1987.
35. Ames, B. N., and Gold, L. S. Chemical carcinogenesis: too many rodent carcinogens. Proc. Natl. Acad. Sci. USA, 87: 7772-7776, 1990.
36. Evans, M. K., Chin, K. V., Gottesman, M. M., and Bohr, V. A. Gene-specific DNA repair and steady state transcription of the MDR1 gene in human tumor cell lines. Oncogene, 12: 651-658, 1996.
37. Wei, D., Maher, V. M., and McCormick, J. J. Site-specific rates of excision repair of benzo[a]pyrene diol epoxide adducts in the hypoxanthine phosphoribosyltransferase gene of human fibroblasts: correlation with mutation spectra. Proc. Natl. Acad. Sci. USA, 92: 2204-2208, 1995.
38. Cerda, S., and Weitzman, S. A. Influence of oxygen radical injury on DNA methylation. Mutat. Res., 386: 141-152, 1997.
39. Ziegler, A., Jonason, A. S., Leffell, D. J., Simon, J. A., Sharma, H. W., Kimmelman, J., Remington, L., Jacks, T., and Brash, D. E. Sunburn and p53 in the onset of skin cancer. Nature (Lond.), 372: 773-776, 1994.
40. Vassar, R., Hutton, M. E., and Fuchs, E. Transgenic overexpression of transforming growth factor a bypasses the need for c-ha-ras mutations in mouse skin tumorigenesis. Mol. Cell. Biol., 12: 4643-4653, 1992.
41. Bailleul, B., Surani, M. A., White, S., Barton, S. C., Brown, K., Blessing, M., Jorcano, J., and Balmain, A. Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter. Cell, 62: 697-708, 1990.
42. Harrington, E. A., Fanidi, A., and Evan, G. I. Oncogenes and cell death. Curr. Opin. Gen. Dev., 4: 120-129, 1994.
43. Evan, G. I., Brown, L., Whyte, M., and Harrington, E. Apoptosis and the cell cycle. Curr. Opin. Cell Biol., 7: 825-834, 1995.
44. L can confer a multidrug resistance phenotype. Blood, 86: 1903-1910, 1995.
45. Scribner, J. D., Scribner, N. K., McKnight, B., and Mottet, N. K. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene. Cancer Res., 43: 2034-2041, 1983.
46. Burns, F. J., Vanderlaan, M., Snyder, E., and Albert, R. E. In: T. J. Slaga, A. Sivak, and R. R. Boutwell. Carcinogenesis: A Comprehensive Survey, pp. 91-96. New York: Raven, 1978.
47. Burns, F. J., Albert, R. E., and Altshyuler, B. In: T. J. Slaga. Mechanisms of Tumor Promotion, pp. 17-39. Boca Raton: CRC, 1984.
48. Hennings, H., Devor, D., Wenk, M. L., Slaga, T. J., Former, B., Colburn, N. H., Bowden, G. T., Elgjo, K., and Yuspa, S. H. Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz(a)anthracene or N-methyl-N'-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice. Cancer Res., 41: 773-779, 1981.
49. Hanahan, D. Dissecting multistep tumorigenesis in transgenic mice. Annu. Rev. Genet., 22: 479-519, 1988.
50. Folkman, J., Watson, K., Ingber, D., and Hanahan, D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature (Lond.), 339: 58-61, 1989.
51. Raff, M. C. Social controls on cell survival and cell death. Nature (Lond.), 356: 397-400, 1992.
52. Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., and Giaccia, A. J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature (Lond.), 379: 88-91, 1996.
53. Holmgren, L., O'Reilly, M. S., and Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med., 1: 149-153, 1995.
54. L promotes susceptibility to mutagenesis. Oncogene, 13: 1489-1497, 1996.
55. Morris, S. M., Domon, O. E., McGarrity, L. J., Chen, J. J., and Casciano, D. A. Programmed cell death and mutation induction in AHH-1 human lymphoblastoid cells exposed to m-AMSA. Mutat. Res., 329: 79-96, 1995.